(Total Views: 416)
Posted On: 08/23/2021 1:06:45 PM
Post# of 149116
There are not two sides to the truth. One side is correct, and one side is wrong.
It is dangerous thinking to say that there are always two sides. How about this one?
1) Leronlimab showed efficacy in a subset of critically ill people in the clinical trial, but they only got 2 doses because the FDA wouldn't let them do the 4-dose regimen. Therefore continuing with clinical trials, with the knowledge gained from this trial, and using the 4-dose regimen, is warranted.
2) The FDA says Leronlimab failed all its endpoints, therefore it is garbage that should be abandoned.
Do those "two sides" have equal validity?
It is dangerous thinking to say that there are always two sides. How about this one?
1) Leronlimab showed efficacy in a subset of critically ill people in the clinical trial, but they only got 2 doses because the FDA wouldn't let them do the 4-dose regimen. Therefore continuing with clinical trials, with the knowledge gained from this trial, and using the 4-dose regimen, is warranted.
2) The FDA says Leronlimab failed all its endpoints, therefore it is garbage that should be abandoned.
Do those "two sides" have equal validity?
(4)
(0)Scroll down for more posts ▼
